publication venue for
- Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression. 9:835-842. 2024
- Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection Fraction. 9:545-545. 2024
- Association of the Timing and Extent of Cardiac Implantable Electronic Device Infections With Mortality. 8:484-484. 2023
- More Attention Should Be Paid to Less Severe Nonculprit Lesions—Reply. 8:514-514. 2023
- Complete Revascularization vs Culprit Lesion–Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction. 7:1091-1091. 2022
- Routine Ultrasonography Guidance for Femoral Vascular Access for Cardiac Procedures. 7:1110-1110. 2022
- Skeletonized Internal Thoracic Artery—Post Hoc Analysis vs Clinical Practice—Reply. 7:988-988. 2022
- Association of Sitting Time With Mortality and Cardiovascular Events in High-Income, Middle-Income, and Low-Income Countries. 7:796-796. 2022
- Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants. 7:747-747. 2022
- Association of Novel Locus With Rheumatic Heart Disease in Black African Individuals. 6:1000-1000. 2021
- Skeletonized vs Pedicled Internal Mammary Artery Graft Harvesting in Coronary Artery Bypass Surgery. 6:1042-1042. 2021
- Screening for Atrial Fibrillation in the Older Population. 6:558-558. 2021
- Error in Methods and Table. 6:246-246. 2021
- Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease:a Subanalysis of the COMPASS Randomized Clinical Trial (vol 6, pg 21, 2021). 6:246-246. 2021
- Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease. 6:21-29. 2021
- Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation. 4:526-526. 2019
- We Can Learn From the Past, but We Must Pave the Future of Congenital Heart Disease Research. 4:599-599. 2019
- Late Stroke After Coronary Artery Bypass Grafting. 3:425-425. 2018
- Association of Depression With Mortality in Older Adults Undergoing Transcatheter or Surgical Aortic Valve Replacement. 3:191-191. 2018
- Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks. 3:225-225. 2018
- Association of Physical Activity With Risk of Major Cardiovascular Diseases in Chinese Men and Women. 2:1349-1349. 2017
- Physical Activity to Prevent Cardiovascular Disease. 2:1358-1358. 2017
- What Do Implanted Cardiac Monitors Reveal About Atrial Fibrillation?. 2:1128-1128. 2017
- Efficacy of Catheter Ablation for Nonparoxysmal Atrial Fibrillation. 2:812-812. 2017
- Laboratory Monitoring of Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation. 2:566-566. 2017
- Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes. 2:370-370. 2017
- Atrial Fibrillation and Cancer—Validation in the Real World—Reply. 2:344-344. 2017
- The Effect of Digital Health Intervention on Reducing Cardiovascular Risk—Reply. 2:346-346. 2017
- The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation. 2:324-324. 2017
- The SPRINT and the HOPE-3 Trial in the Context of Other Blood Pressure–Lowering Trials. 1:857-857. 2016
- Participation Rates With Opt-out Enrollment in a Remote Monitoring Intervention for Patients With Myocardial Infarction. 1:847-847. 2016
- Appropriate Apixaban Dosing. 1:635-635. 2016
- A Digital Health Intervention to Lower Cardiovascular Risk. 1:601-601. 2016
- Risk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation. 1:389-389. 2016